Gene therapy for cystic fibrosis: which postman, which box?
Open Access
- 1 March 1998
- Vol. 53 (3) , 197-199
- https://doi.org/10.1136/thx.53.3.197
Abstract
Since 1989 when the gene responsible for cystic fibrosis was cloned and designated the cystic fibrosis transmembrane conductance regulator (CFTR) gene, considerable progress has been made in the development of gene therapy for this disease. Clinical trials have already been performed using cationic liposome and adenoviral based gene transfer systems, measuring the safety and efficacy of this new form of treatment, with variable results to date. These two approaches and the current progress in airway gene delivery are discussed.Keywords
This publication has 12 references indexed in Scilit:
- A demonstration using mouse models that successful gene therapy for cystic fibrosis requires only partial gene correction.1996
- Gene transfer into the airway epithelium of animals by targeting the polymeric immunoglobulin receptor.Journal of Clinical Investigation, 1995
- Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epitheliumEuropean Respiratory Journal, 1994
- Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosisNature Genetics, 1994
- Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosisNature Genetics, 1994
- Nasal application of the cationic liposome DC-Chol:DOPE does not alter ion transport, lung function or bacterial growthEuropean Respiratory Journal, 1994
- Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosisPublished by Elsevier ,1993
- Non–invasive liposome–mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant miceNature Genetics, 1993
- Mode of formation and structural features of DNA-cationic liposome complexes used for transfectionBiochemistry, 1993
- Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosisNature Genetics, 1992